AFP and hepatocellular carcinoma: Next, candidate miRNAs were measured in sera samples of HCC patients and healthy controls by quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR), and their potential use as markers for the diagnosis of HCC were assessed and compared with AFP.